Description
A naphthoquinone with diverse biological activities; inhibits U-46619-induced rabbit platelet aggregation in vitro (IC50 = 0.58 μM); inhibits the conversion of arachidonic acid to thromboxane B2 in rabbit platelets; inhibits human platelet aggregation induced by ADP, collagen, epinephrine, and A23187 in vitro (IC50s = 3.21, 15.69, 8.44, and 44.2 μM, respectively); increases tail bleeding time and exhibits a protective effect against pulmonary thrombosis in mice at 50 and 100 mg/kg; inhibits CD45 (IC50 = 0.29 μM); inhibits ovalbumin-induced footpad swelling in a mouse model of delayed-type hypersensitivity at 3 mg/kg; is active against C. albicans, A. niger, B. subtilis, S. aureus, E. coli, and P. aeruginosa (MICs = 12.5-50 μg/ml)
Formal name: 2-[(4-acetylphenyl)amino]-3-chloro-1,4-naphthalenedione
Synonyms:
Molecular weight: 325.8
CAS: 130089-98-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antibiotics||Product Type|Biochemicals|Antifungals||Product Type|Biochemicals|Small Molecule Inhibitors|Phosphatases||Research Area|Cardiovascular System|Blood|Coagulation & Hemostasis||Research Area|Cardiovascular System|Blood|Thrombosis||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases||Research Area|Infectious Disease|Fungal Diseases|Candidiasis||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway